NCT03361358View on ClinicalTrials.gov

Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Advanced Solid TumorsLymphoma
Trial Locations (3)

37203

Nashville, TN, Nashville

02114

Boston, MA, Boston

08035

Barcelona, Spain, Barcelona

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY